Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Why Investors Shouldn’t Bet on iBio Stock Now

By Larry Ramer, InvestorPlace Contributor

There's a much better way for investors to profit from a coronavirus vaccine than IBIO stock.

Worries About Disruptive Fastly Are Overdone

By Larry Ramer, InvestorPlace Contributor

Given the apparent technological superiority of Fastly and the economy's rapid digitalization, long-term investors should buy FSLY stock.

As It Becomes a Heavy-Hitter in Ad Technology, Roku Stock Is Set to Soar

By Larry Ramer, InvestorPlace Contributor

Roku generated strong growth in Q2, while Roku stock has multiple, strong, positive catalysts.

Investors Shouldn’t Pull the Trigger on Genius Brands Stock Yet

By Larry Ramer, InvestorPlace Contributor

Genius Brands has a great deal of potential, but investors shouldn't pull the trigger on GNUS stock yet.

XpresSpa Shares Are Facing More Problems

By Larry Ramer, InvestorPlace Contributor

With a vaccine potentially two or three months away, XpressSpa appears to be moving at a snail's pace, increasing the risk posed by XSPA stock.

Load More